Radiology Journals

Radiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Viani GA et al. – The meta–analysis showed that HDRT is superior to CDRT in preventing biochemical failure in low–, intermediate–, and high–risk prostate cancer patients, suggesting that this should be offered as a treatment for all patients, regardless of their risk status.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address